Stock NB3 NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Neurocrine Biosciences, Inc. Deutsche Boerse AG

Equities

NB3

US64125C1099

Market Closed - Deutsche Boerse AG
Other stock markets
 09:58:09 31/05/2024 pm IST 		5-day change 1st Jan Change
124 EUR +0.61% Intraday chart for Neurocrine Biosciences, Inc. -4.36% +4.38%
31/05 Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing MT
28/05 Neurocrine Biosciences Says CEO Kevin Gorman Retiring MT

Chart calendar Neurocrine Biosciences, Inc.

94b893046759650bf8.cXYVhpLkrPbJR3rNC88TbEDj198gVzrFedFqGFaUqQU.AURXsaej-cGrNyyFXZxJDRKOk75EFAiyTOIAViX34DIZN2fqoKvEhaEdNw~4fe78420c0ae0ff173bb56b4c8acf499

Upcoming events on Neurocrine Biosciences, Inc.

06/06/2024 12:00 am Jefferies Global Healthcare Conference
13/06/2024 08:10 pm Goldman Sachs Global Healthcare Conference
30/07/2024 Q2 2024 Earnings Release (Projected)
29/10/2024 Q3 2024 Earnings Release (Projected)
11/02/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Neurocrine Biosciences, Inc.

22/05/2024 11:00 pm Annual General Meeting
14/05/2024 11:50 pm BofA Securities Health Care Conference
11/05/2024 06:00 pm American Association of Clinical Endocrinology Meeting - Abstract No:05
10/05/2024 09:30 pm American Association of Clinical Endocrinology Meeting
10/05/2024 08:40 pm American Association of Clinical Endocrinology Meeting - Abstract No:14
01/05/2024 05:30 pm Q1 2024 Earnings Call
01/05/2024 04:30 pm Q1 2024 Earnings Release
19/03/2024 11:30 pm Stifel Virtual CNS Conference
18/03/2024 09:30 pm UBS Virtual CNS Day
13/03/2024 07:45 pm Barclays Global Healthcare Conference
12/03/2024 06:10 pm Leerink Partners Global Biopharma Conference
05/03/2024 09:40 pm TD Cowen Health Care Conference
07/02/2024 06:30 pm Q4 2023 Earnings Call
07/02/2024 05:30 pm Q4 2023 Earnings Release
09/01/2024 11:15 pm JPMorgan Healthcare Conference
05/12/2023 11:30 pm Analyst Day
14/11/2023 08:30 pm Jefferies London Healthcare Conference
09/11/2023 NEI Congress
02/11/2023 Huntington Study Group Meeting - Poster Number # 66
02/11/2023 Huntington Study Group Meeting - Poster Number # 62

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		788
776
1.52%		1 046
1 058
-1.18%		1 134
1 139
-0.47%		1 489
1 484
0.31%		1 887
1 885
0.1%
2 219

EBITDA
Million USD		Released
Forecast
Spread 		79,7
114
-30.31%		192
178
7.55%		131
232
-43.66%		264
336
-21.3%		269
281
-4.33%
556

EBIT
Million USD		Released
Forecast
Spread 		72,3
105
-31.23%		163
162
0.44%		103
209
-51.06%		249
289
-13.9%		251
258
-2.84%
565

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		46,5
87,9
-47.11%		107
129
-17.29%		101
181
-43.99%		214
241
-11.43%		332
296
12.11%
538

Net income
Million USD		Released
Forecast
Spread 		37,0
78,4
-52.81%		407
121
236.66%		89,6
148
-39.37%		155
188
-17.63%		250
225
11.11%
426

EPS
USD		Released
Forecast
Spread 		0,39
0,82
-52.34%		4,16
1,23
238.86%		0,92
1,51
-39.1%		1,56
1,88
-17.15%		2,47
2,22
11.3%
4,06

Announcement Date04/02/2004/02/2111/02/2206/02/2307/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		311
304
2.15%		378
343
10.12%		388
377
2.96%		412
409
0.74%		420
409
2.78%		453
448
1.05%		499
479
4.13%		515
518
-0.62%		515
512
0.64%
547


569


590


588


616

EBITDA
Million USD		Released
Forecast
Spread 		6,80
43,3
-84.3%		59,0
75,6
-21.96%		91,8
109
-16.04%		107
155
-30.67%		-109
42,8
-355.18%		78,7
126
-37.5%		144
147
-1.74%		155
149
4.23%		106
127
-16.67%
146


159


136







EBIT
Million USD		Released
Forecast
Spread 		3,10
39,1
-92.07%		54,7
66,7
-17.94%		87,8
96,8
-9.28%		103
136
-23.91%		-114
14,7
-874.64%		73,6
99,5
-26.06%		141
125
12.9%		150
154
-2.64%		99,3
118
-15.82%
145


161


170


156


181

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		21,4
33,6
-36.38%		-23,3
61,7
-137.75%		97,9
89,2
9.71%		118
135
-12.69%		-103
33,1
-412.49%		122
98,0
24.07%		116
132
-12.2%		198
159
24.47%		34,5
129
-73.3%
137


174


182


149


174

Net income
Million USD		Released
Forecast
Spread 		13,9
30,8
-54.88%		-16,9
58,1
-129.08%		68,5
76,2
-10.08%		89,0
118
-24.66%		-76,6
8,27
-1026.71%		95,5
75,4
26.62%		83,1
97,8
-15.04%		148
115
28.34%		43,4
101
-57.11%
112


132


145


114


133

EPS
USD		Released
Forecast
Spread 		0,14
0,33
-57.17%		-0,18
0,62
-128.85%		0,69
0,79
-13.19%		0,88
1,15
-23.33%		-0,79
0,04
-2143.98%		0,95
0,77
23.93%		0,82
0,97
-15.1%		1,44
1,12
28.46%		0,42
1,00
-57.99%
1,03


1,25


1,31


1,18


1,40

Announcement Date04/05/2204/08/2201/11/2206/02/2303/05/2301/08/2331/10/2307/02/2401/05/24-----

Upcoming sector events for Neurocrine Biosciences, Inc.

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Neurocrine Biosciences, Inc.

17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 05:30 pm IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. NB3 Stock
  5. Calendar Neurocrine Biosciences, Inc.